Treatment of cutaneous T-cell lymphoma with dacarbazine in a dog

Veterinary Dermatology

Volumn 8, Issue 1, 1997, Pages 41-46

  Lemarié, Stephen L ^a,b   Eddlestone, Susan M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Companion Anim Dermatol R ^*  (United States)

Author keywords

Clonogenic assay; Cutaneous T cell lymphoma; Dacarbazine; Dog

Indexed keywords

EID: 0031482040     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3164.1997.tb00262.x     Document Type: Article

References (29)

1. Couto, C.G. Cutaneous Lymphomas. Proceedings of the 11th Kalkan Symposium 1987; 71-7.
2. Goldschmidt, M.H., Shofer, F.S. Skin Tumors of the Dog and Cat. New York: Pergamon Press Inc., 1992: 252-64.
3. Moore, P.E., Olivry, T. Cutaneous lymphomas in companion animals. Clinics in Dermatology 1994; 499-505.
4. Beale, K.M., Dill-Macky, E., Meyer, D.J. et al. An unusual presentation of cutaneous lymphoma in two dogs. Journal of the American Animal Hospital Association 1990; 429-32.
5. Wilcock, B.P., Yager, J.A. The behavior of epidermotrophic lymphoma in twenty-five dogs. Canadian Veterinary Journal 1989; 30:754-6.
6. Beale, K.M., Bolon, B. Canine cutaneous lymphosarcoma: Epitheliotropic and nonepitheliotropic: A retrospective study. In: Ihrke, P.J., Mason, I.S., White, S.D., eds. Advances in Veterinary Dermatology, Vol. 2. Oxford: Pergamon Press, 1993: 273-84.
7. Moore, P.F., Olivry, T., Naydan, D. Canine cutaneous epitheliotropic lymphoma (Mycosis Fungoides) is a proliferative disorder of CD8+ cells. American Journal of Pathology 1994; 144: 421-9.
8. Haines, D.H., Chelack, B.J. Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology. Journal of Veterinary Diagnostic Investigation 1991; 3: 101-12.
9. Mason, D.Y., Cordell, J., Brown, M. et al. Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. Journal of Clinical Pathology 1989; 42: 1194-1200.
10. Hildebrand-Zanki, S.U, Kern, D.H. In vitro assays for new drug screening: comparison of a thymidine incorporation assay with the human tumor-colony forming assay. International Journal of Cell Cloning 1987; 5: 421-31.
11. Rosenthal, R.C. Chemotherapy. In: Ettinger, S., Feldman, E., eds. Textbook of Internal Medicine, 4th edn. Philadelphia: W.B. Saunders, 1995; 473-84.
12. Brown, N.O., Nesbitt, G.B., Patnaik, A.K. et al. Cutaneous lymphosarcoma in the dog: A disease with variable clinical and histologic manifestations. Journal of the American Animal Hospital Association 1980; 16: 565-72.
13. Knowles, D.M. Immunophenotypic and antigen receptor gene rearrangement analysis in T-cell neoplasia. American Journal of Pathology 1989; 134: 761-85.
14. Ralfkiaer, E. Immunohistological markers for the diagnosis of cutaneous lymphomas. Seminars in Diagnostic Pathology 1991; 8: 62-72.
15. Ackerman, L. Oral T cell-like lymphoma in a dog. Journal of the American Animal Hospital Association 1984; 20: 955-8.
16. Rosenkrantz, W.S., Griffin, G.E., Barr, R.J. Clinical evaluation of cyclosporine in animal models with cutaneous immune-mediated disease and epitheliotropic lymphoma. Journal of the American Animal Hospital Association 1989; 25: 377-84.
17. White, S.D., Rosychuk, R.A.W., Scott, K.V. Use of isotretinoin and etretinate for the treatment of benign cutaneous neoplasia and cutaneous lymphoma in dogs. Journal of the American Veterinary Medical Association 1993; 202: 387-91.
18. Bender, W.M. Nontraditional treatment of mycosis fungoides in a dog. Journal of the American Veterinary Medical Association 1984; 185: 900-1.
19. DeBoer, D.J., Turrel, J.M., Moore, P.F. Mycosis fungoides in a dog: Demonstration of T-cell specificity and response to radiotherapy. Journal of the American Animal Hospital Association 1990; 26: 566-72.
20. Van Vechten, M., Helfand, S., Jeglum, A. Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine. Journal of Veterinary Internal Medicine 1990; 4: 187-91.
21. Thompson, J.P. Antineoplastics agents in cancer therapy. In: Kirk, R., Bonagura, J., eds. Current Veterinary Therapy XI Small Animal Practice. Philadelphia: W.B. Saunders, 1992; 1272.
22. Hammer, A.S., Couto, C.G. Adjuvant chemotherapy for sarcomas and carcinomas. Veterinary Clinics of North America: Small Animal Practice 1990; 20: 1015-35.
23. Hamburger, A.W., Salmon, S.E. Primary bioassay of human tumor stem cells. Science 1977; 197: 461-3.
24. Von Hoff, D.D. He's not going to talk about in vitro predictive assays again, is he? Journal of the National Cancer Institute. 1990; 82: 96-101.
25. Hoffman, R.M. In vitro sensitivity assays in cancer: A review, analysis and prognosis. Journal of Clinical Laboratory Analysis 1991; 5: 133-43.
26. Schadendorf, D., Worm, M., Algermissen, B. et al. Chemosensitivity testing of human malignant melanoma A retrospective analysis of clinical response and in vitro drug sensitivity. Cancer 1994; 73: 103-8.
27. Gazdar, A.F., Steinberg, S.M., Russell, E.K. et al. Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial. Journal of the National Cancer Institute 1990; 82: 117-24.
28. Von Hoff, D.D., Kronmal, R., Salmon, S.E. et al. A southwest oncology group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer. Cancer 1991; 67: 20-7.
29. Sevin, B.U., Perras, J.P., Averette, H.E. et al. Chemosensitivity testing in ovarian cancer. Cancer 1993; 71: 1613-20.